Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapies for obesity, diabetes and related indications

Therapies for obesity, diabetes and related indications

US Patent 10660939 · Granted May 26, 2020

Estimated economic value: $1,677,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orally active melanocortin receptor-4 compounds2025
Melanocortin receptor-specific peptides2020
Uses of bremelanotide in therapy for female sexual dysfunction2019
Melanocortin receptor-specific peptides2019
Compounds inhibiting eukaryotic elongation factor 2 kinase activity2018
Uses of bremelanotide in therapy for female sexual dysfunction2017
Melanocortin receptor-specific heptapeptides2016
Uses of bremelanotide in therapy for female sexual dysfunction2016
Melanocortin receptor-specific peptides2015
Melanocortin receptor-specific peptides2014
Melanocortin receptor-specific peptides2013
Melanocortin receptor-specific peptides2013